In melanoma, VISTA expression in tumor-infiltrating immune cells in 85 primary melanoma specimens was associated with significantly worse disease-specific survival (p = 0.005) and emerged as an independent negative prognostic factor in multivariate analyses (p = 0.02) [120]. This evidence concerns the gene VSIR and neoplasm.